相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Editing aberrant splice sites efficiently restores β-globin expression in β-thalassemia
Shuqian Xu et al.
BLOOD (2019)
Direct Promoter Repression by BCL11A Controls the Fetal to Adult Hemoglobin Switch
Nan Liu et al.
CELL (2018)
Safety and efficacy of plerixafor dose escalation for the mobilization of CD34+ hematopoietic progenitor cells in patients with sickle cell disease: interim results
Farid Boulad et al.
HAEMATOLOGICA (2018)
Plerixafor enables safe, rapid, efficient mobilization of hematopoietic stem cells in sickle cell disease patients after exchange transfusion
Chantal Lagresle-Peyrou et al.
HAEMATOLOGICA (2018)
Natural regulatory mutations elevate the fetal globin gene via disruption of BCL11A or ZBTB7A binding
Gabriella E. Martyn et al.
NATURE GENETICS (2018)
p53 inhibits CRISPR-Cas9 engineering in human pluripotent stem cells
Robert J. Ihry et al.
NATURE MEDICINE (2018)
CRISPR-Cas9 genome editing induces a p53-mediated DNA damage response
Emma Haapaniemi et al.
NATURE MEDICINE (2018)
Safety and efficacy of plerixafor dose escalation for the mobilization of CD34+ hematopoietic progenitor cells in patients with sickle cell disease: interim results
Farid Boulad et al.
HAEMATOLOGICA (2018)
Plerixafor enables safe, rapid, efficient mobilization of hematopoietic stem cells in sickle cell disease patients after exchange transfusion
Chantal Lagresle-Peyrou et al.
HAEMATOLOGICA (2018)
Repair of double-strand breaks induced by CRISPR-Cas9 leads to large deletions and complex rearrangements (vol 36, pg 765, 2018)
Michael Kosicki et al.
NATURE BIOTECHNOLOGY (2018)
A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells
Christopher A. Vakulskas et al.
NATURE MEDICINE (2018)
Successful hematopoietic stem cell mobilization and apheresis collection using plerixafor alone in sickle cell patients
Erica B. Esrick et al.
BLOOD ADVANCES (2018)
CIRCLE-seq: a highly sensitive in vitro screen for genome-wide CRISPR Cas9 nuclease off-targets
Shengdar Q. Tsai et al.
NATURE METHODS (2017)
CRISPR-Cas9 gene repair of hematopoietic stem cells from patients with X-linked chronic granulomatous disease
Suk See De Ravin et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Long-Term Engraftment and Fetal Globin Induction upon BCL11A Gene Editing inBone-Marrow-Derived CD34+ Hematopoietic Stem and Progenitor Cells
Kai-Hsin Chang et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2017)
Therapeutic gene editing in CD34+ hematopoietic progenitors from Fanconi anemia patients
Begona Diez et al.
EMBO MOLECULAR MEDICINE (2017)
Deoxygenation Reduces Sickle Cell Blood Flow at Arterial Oxygen Tension
Xinran Lu et al.
BIOPHYSICAL JOURNAL (2016)
Strict in vivo specificity of the Bcl11a erythroid enhancer
Elenoe C. Smith et al.
BLOOD (2016)
Validation and Implementation of a Custom Next-Generation Sequencing Clinical Assay for Hematologic Malignancies
Michael. J. Kluk et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2016)
Fetal haemoglobin in sickle-cell disease: from genetic epidemiology to new therapeutic strategies
Guillaume Lettre et al.
LANCET (2016)
CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells
Daniel P. Dever et al.
NATURE (2016)
Analyzing CRISPR genome-editing experiments with CRISPResso
Luca Pinello et al.
NATURE BIOTECHNOLOGY (2016)
A genome-editing strategy to treat β-hemoglobinopathies that recapitulates a mutation associated with a benign genetic condition
Elizabeth A. Traxler et al.
NATURE MEDICINE (2016)
Selection-free genome editing of the sickle mutation in human adult hematopoietic stem/progenitor cells
Mark A. DeWitt et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Highly Efficient Genome Editing of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9
Michael C. Gundry et al.
CELL REPORTS (2016)
Correction of the sickle cell disease mutation in human hematopoietic stem/progenitor cells
Megan D. Hoban et al.
BLOOD (2015)
miRNA-embedded shRNAs for Lineage-specific BCL11A Knockdown and Hemoglobin F Induction
Swaroopa Guda et al.
MOLECULAR THERAPY (2015)
BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis
Matthew C. Canver et al.
NATURE (2015)
Homology-driven genome editing in hematopoietic stem and progenitor cells using ZFN mRNA and AAV6 donors
Jianbin Wang et al.
NATURE BIOTECHNOLOGY (2015)
Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells
Ayal Hendel et al.
NATURE BIOTECHNOLOGY (2015)
Functional footprinting of regulatory DNA
Jeff Vierstra et al.
NATURE METHODS (2015)
Microhomology-Mediated End Joining: A Back-up Survival Mechanism or Dedicated Pathway?
Agnel Sfeir et al.
TRENDS IN BIOCHEMICAL SCIENCES (2015)
Nonirradiated NOD,B6.SCID Il2rγ-/- KitW41/W41 (NBSGW) Mice Support Multilineage Engraftment of Human Hematopoietic Cells
Brian E. McIntosh et al.
STEM CELL REPORTS (2015)
Global transcriptome analyses of human and murine terminal erythroid differentiation
Xiuli An et al.
BLOOD (2014)
Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins
Sojung Kim et al.
GENOME RESEARCH (2014)
Targeted genome editing in human repopulating haematopoietic stem cells
Pietro Genovese et al.
NATURE (2014)
Microhomology-based choice of Cas9 nuclease target sites
Sangsu Bae et al.
NATURE METHODS (2014)
Microhomology-mediated End Joining and Homologous Recombination share the initial end resection step to repair DNA double-strand breaks in mammalian cells
Lan N. Truong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
An Erythroid Enhancer of BCL11A Subject to Genetic Variation Determines Fetal Hemoglobin Level
Daniel E. Bauer et al.
SCIENCE (2013)
Hematopoietic Stem Cell Quiescence Promotes Error-Prone DNA Repair and Mutagenesis
Mary Mohrin et al.
CELL STEM CELL (2010)
Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo
Nathalia Holt et al.
NATURE BIOTECHNOLOGY (2010)